TL;DR: The Centers for Medicare & Medicaid Services modified NCD 202 governing uroflowmetric evaluations, effective March 7, 2026. Here's what billing teams need to know.
CMS uroflowmetric evaluation coverage policy under NCD 202 Medicare has been updated. The policy confirms Medicare coverage for uroflowmetric evaluations—also called urodynamic voiding studies or urodynamic flow studies—used to diagnose urological dysfunctions, including bladder outlet obstructions. NCD 202 is the National Coverage Determination that governs Medicare coverage for these diagnostic tests. The policy does not list specific CPT or HCPCS codes, which creates a documentation burden your billing team needs to address now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Uroflowmetric Evaluations — NCD 202 |
| Policy Code | NCD 202 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Urology, Urogynecology, Primary Care (with urological billing) |
| Key Action | Audit uroflowmetry claims for medical necessity documentation before March 7, 2026 |
CMS Uroflowmetric Evaluation Coverage Criteria and Medical Necessity Requirements 2026
NCD 202 places uroflowmetric evaluations in the diagnostic tests benefit category. Medicare covers these studies when they're used to diagnose urological dysfunctions, including bladder outlet obstructions.
That last phrase is the one to watch. "Including" is not "limited to." The policy language signals that bladder outlet obstruction is an example of a covered indication—not an exhaustive list. Your billing team should treat this as a broad diagnostic benefit, not a narrow one.
Medical necessity is still the deciding factor on every claim. Uroflowmetric evaluation billing must tie directly to a documented clinical reason for the study. "Rule out obstruction" or "evaluate voiding dysfunction" in the clinical notes supports the claim. A note that just says "voiding study ordered" does not.
Whether uroflowmetric evaluation is covered under Medicare depends on the medical necessity documentation attached to the claim—not just the diagnosis code. CMS does not require prior authorization for uroflowmetric evaluations under NCD 202, but your Medicare Administrative Contractor may have a local coverage determination that adds criteria. Check your MAC's LCD library before assuming NCD 202 is your only governing document.
The coverage policy sits at the national level. That means NCD 202 preempts any MAC policy that would restrict coverage more narrowly—but it does not prevent MACs from adding documentation requirements. The real issue here is that billing teams often skip the LCD check when a national NCD exists. Don't do that.
Reimbursement for these studies flows through the physician fee schedule for professional services and the outpatient fee schedule for hospital-based billing. The absence of specific codes in the NCD itself means your coding team bears the full responsibility for selecting the right CPT or HCPCS codes and defending that selection with documentation.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Bladder outlet obstruction — diagnosis | Covered | Not specified in NCD 202 | Confirm CPT selection against MAC LCD |
| Urological dysfunctions — diagnostic evaluation | Covered | Not specified in NCD 202 | Medical necessity documentation required |
| Urodynamic voiding studies (alternate descriptor) | Covered | Not specified in NCD 202 | Same service, different clinical terminology |
| Urodynamic flow studies (alternate descriptor) | Covered | Not specified in NCD 202 | Same service, different clinical terminology |
CMS Uroflowmetric Evaluation Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 is your line in the sand. Here's what to do before and after that date.
| # | Action Item |
|---|---|
| 1 | Pull your MAC's LCD for urodynamics now. NCD 202 sets the national floor, but your MAC may have issued a local coverage determination with additional documentation requirements or diagnosis code restrictions. Find your MAC at cms.gov and search their LCD database for urodynamic or uroflowmetry policies. Do this before March 7, 2026. |
| 2 | Audit your medical necessity documentation templates. Every uroflowmetric evaluation claim needs a documented clinical reason for the study. Review your intake and order templates. Make sure physicians are capturing the specific voiding complaint or dysfunction that prompted the test—not just listing the procedure. |
| 3 | Identify the CPT codes your practice uses for uroflowmetric evaluations. NCD 202 does not list specific codes. That doesn't mean anything goes—it means your coding team must select the right codes and document the rationale. If you're not sure which CPT codes apply to your specific studies, get your coding consultant involved before the effective date. |
| 4 | Check your charge capture for urodynamic flow studies. Confirm that the description on your charge master matches what your MAC's LCD expects. Mismatched clinical terminology between the order, the operative or procedure report, and the claim is a common source of claim denial for urodynamic services. |
| 5 | Review your payer mix beyond Medicare. NCD 202 only governs Medicare. If you bill Aetna, Cigna, or UnitedHealthcare for uroflowmetric evaluations, those payers have separate coverage policies. A change to the CMS coverage policy does not update commercial payer criteria. |
| 6 | Flag this for your compliance officer if your practice does high uroflowmetry volume. Medium-impact policies like this one don't always trigger internal review. If uroflowmetry billing is a significant line of revenue for your practice, loop in your compliance officer to assess whether your documentation practices hold up under the updated NCD. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Uroflowmetric Evaluations Under NCD 202
The policy data for NCD 202 does not include specific CPT, HCPCS, or ICD-10 codes.
This is not unusual for an NCD. National coverage determinations often define the service and the covered indications without specifying codes—leaving code selection to the billing team and MAC-level guidance.
What This Means for Your Billing Team
You're responsible for selecting the correct procedure codes. Your MAC's local coverage determination is the most important document to pull right now. MACs frequently publish covered ICD-10 diagnosis codes alongside their urodynamics LCDs, and those lists are what determine whether a claim gets paid or denied.
If your MAC has an active LCD for urodynamic testing, that LCD's covered diagnosis code list is your working document. If there's no LCD, you're coding to the NCD's intent—and your documentation has to do the heavy lifting.
Do not assume a code is covered because the NCD exists. The NCD establishes that Medicare covers uroflowmetric evaluations. Your MAC, your code selection, and your documentation determine whether a specific claim pays.
If you're billing for complex urodynamic studies beyond simple uroflowmetry, talk to your coding consultant. The CPT range for urodynamic services spans multiple codes with distinct definitions. Selecting the wrong one—even with solid medical necessity documentation—produces a claim denial.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.